Today in News History

On July 12, several notable moments in the history of News stand out. In 1905, Betty Allan, Australian statistician and biometrician (died 1952) was born. In 1944, Michael Levy, Baron Levy, English philanthropist was born. In 1944, Lou Hudson, American basketball player and coach (died 2014) was born. In 1953, Ivan Toms, South African physician and activist (died 2008) was born. In 1955, Balaji Sadasivan, Singaporean neurosurgeon and politician, Singaporean Minister of Health (died 2010) was born. In 1959, Suzanne Vega, American singer-songwriter, guitarist, and producer was born. In 1965, Ernesto Hoost, Dutch kick-boxer and sportscaster was born. In 1968, Michael Geist, Canadian journalist and academic was born. In 1978, Massimiliano Rosolino, Italian swimmer was born. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

DASH diet proves superior for blood pressure control in landmark study of 83,000 patients

NaturalNews.com

NaturalNews.com

·

July 2, 2026

·

right
Narrative Analysis: Bandwagon

(NaturalNews) A study of 83,248 UK Biobank participants with high blood pressure found the DASH diet reduced heart disease risk by 15 and mortality by 22. ...

Narrative Intelligence Brief

This article was published by NaturalNews.com, a source frequently categorized with a right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. In this specific piece, our systems detected the potential use of the "Bandwagon" technique. This narrative approach is often used to shape reader perception by highlighting specific emotional or rhetorical angles. By understanding the editorial perspective of NaturalNews.com, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Reliability Insights

P

Technique: Bandwagon
System analysis detected use of specific narrative techniques in this piece.
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 17%

Center 50%

Right 17%


The Eastern Herald

center

· Jul 2, 2026

Statins and Blood Pressure Drugs Are Closing the Heart-Risk Gap Between Obese and Normal-Weight Adults, Study Finds

A Lancet study tracking nearly one million people across seven countries found that obese adults over 60 now show blood pressure and cholesterol profiles nearly identical to normal-weight peers, driven by widespread statin and antihypertensive use. Researchers warn this reflects pharmaceutical management of cardiovascular risk, not safer obesity.

NaturalNews.com

right

· Jun 23, 2026

Study: Lifestyle Changes Reduce Chronic Disease Risk in Prediabetes by 21%

(NaturalNews) Key Findings: Diet, Weight Loss, Exercise Outperform MetforminA 21-year study published in JAMA found that adults with prediabetes who followed an i...

mindbodygreen

center

· Jul 6, 2026

The Everyday Foods Researchers Linked To A Lower Diabetes Risk

Get ready to stock your pantry with all the good stuff.

Gary Taubes

center

· Jan 22, 2024

Substack 4: Nutrition Researchers Say It’s the Doctors Who Are Fooling Themselves – Are They?

The very controversial history surrounding dietary therapy for obesity and diabetes comes down to one consistent and very obvious conflict. Physicians, like the UK’s David Unwin in his recent article, insist that they know better how to successfully treat their patients than the academic nutritionists and epidemiologists in their Ivy Towers. The physicians have argued...Read More »

Foreign Policy Journal

left

· Jun 26, 2026

Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access

Novo Nordisk (CPSE:NOVO B) has received UK regulatory approval for an oral version of Wegovy, making it the first authorized daily GLP-1 pill for weight management in the country. The approval covers obese and overweight adults, providing a meaningful alternative to injectable GLP-1 therapies that have dominated the obesity treatment landscape. The decision is expected [] The post Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access appeared first on Foreign Policy Journal.

Scientific American

Unknown

· Jun 25, 2026

Weight loss drugs don't work for everyone—here’s why

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why may be genetics

Topics:

Health · 3
World · 1
Unknown · 1
Science · 1

Related coverage for "DASH diet proves superior for blood pressure control in landmark study of 83,000 patients": The Eastern Herald — Statins and Blood Pressure Drugs Are Closing the Heart-Risk Gap Between Obese and Normal-Weight Adults, Study Finds. NaturalNews.com — Study: Lifestyle Changes Reduce Chronic Disease Risk in Prediabetes by 21%. mindbodygreen — The Everyday Foods Researchers Linked To A Lower Diabetes Risk. Gary Taubes — Substack 4: Nutrition Researchers Say It’s the Doctors Who Are Fooling Themselves – Are They?. Foreign Policy Journal — Novo Nordisk (CPSE:NOVO B) Secures UK Approval For Once-Daily Oral Wegovy Pill, Reshaping Obesity Treatment Access. Scientific American — Weight loss drugs don't work for everyone—here’s why